DoW Pancreatic Cancer Research Program, Idea Development Award
About
Summary: The fiscal year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. This award mechanism supports innovative ideas with the potential to yield impactful data and new avenues of investigation. All applications must address at least one of the FY26 PCARP Focus Areas. Distinctive Features: This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials. Partnering Principal Investigator (PI) Option for Early-Career Investigator: This funding mechanism offers a higher level of funding for applications that propose to partner an experienced PI (i. e., Initiating PI, who will serve as the mentor) with an Early-Career Investigator (i. e., Partnering PI) wishing to pursue a career in pancreatic cancer research. For this option, only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administrati.
The DoW Pancreatic Cancer Research Program (PCARP) Idea Development Award supports researchers pursuing innovative, high-risk/high-reward research projects with the potential to accelerate progress in pancreatic cancer treatment and outcomes. This award mechanism is designed for investigators who have developed preliminary data demonstrating the feasibility of their proposed research direction. The program funds clinical research studies, though clinical trials are not eligible under this mechanism. Researchers should apply if they have a novel research idea addressing at least one of the FY26 PCARP Focus Areas and possess preliminary data to support their project's viability. The program offers special consideration for early-career investigators through a Partnering Principal Investigator option, which pairs experienced mentors with emerging researchers seeking to establish careers in pancreatic cancer research. This funding opportunity attracts principal investigators from academic institutions, research organizations, and medical centers nationwide who are committed to breakthrough discoveries that could transform pancreatic cancer patient outcomes. If you have foundational data supporting an innovative research concept and seek resources to develop it further, this award represents a strategic opportunity to advance your pancreatic cancer research agenda.
Funding Facts
● Applications openDeadline
October 7, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle - consult official program
Deadline
2026-10-07
Grant Type
federal
Application Cycle
Annual - Deadline October 7, 2026
Best For
Principal Investigators and early-career researchers pursuing innovative pancreatic cancer research with preliminary data
Frequently Asked Questions
Who is eligible for DoW Pancreatic Cancer Research Program, Idea Development Award?
Specific eligibility criteria are not provided in the available listing information. However, based on the program structure, eligible applicants likely include principal investigators at research institutions, universities, and medical centers. The program offers a special Partnering PI option for early-career investigators paired with experienced mentors. For detailed eligibility requirements, institutional affiliations, citizenship status, and other specific criteria, visit the official Department of Defense or sponsoring agency website, as these details vary by funding cycle.
How much funding does DoW Pancreatic Cancer Research Program, Idea Development Award provide?
The specific funding amount or range for this award is not specified in the available information. Award amounts may vary based on the scope of the proposed research, the qualifications of the principal investigators, and annual budget allocations. For current funding levels and budget details, consult the official program announcement or the Department of Defense's grant management portal.
How do I apply for DoW Pancreatic Cancer Research Program, Idea Development Award?
The application process typically involves submitting a pre-application followed by a full application if selected to proceed. For the Partnering PI option, only the Initiating PI submits the pre-application; both PIs submit at the full application stage, with the Partnering PI providing an abbreviated application package. All applications must address at least one FY26 PCARP Focus Area and include preliminary data relevant to the proposed project. For detailed submission instructions, required documentation, and application portals, visit the official program website or your institution's research administration office.
What can DoW Pancreatic Cancer Research Program, Idea Development Award funding be used for?
This award supports the development of innovative, high-risk/high-reward pancreatic cancer research that could lead to critical discoveries or major advancements. Funding can support clinical research studies that address designated FY26 PCARP Focus Areas. However, clinical trials are not eligible under this mechanism. The award is intended to generate impactful preliminary data and open new investigative pathways in pancreatic cancer research. For specifics on allowable expenses and research focus areas, consult the official program guidelines.
Last updated: July 5, 2026